Back to Search
Start Over
Mast Cells as a Double Edged Sword in Immunity: Disorders of Mast Cell Activation and Therapeutic Management. Second of Two Parts
- Source :
- Endocrine, metabolicimmune disorders drug targets. 20(5)
- Publication Year :
- 2019
-
Abstract
- Mast cells (MCs) bear many receptors which allow them to respond tAs far as treatment of MC-derived diseases is concerned, allergen immunotherapy as well as other attempts to reduce MC-activation will be outlined according to the recent data. Finally, in agreement with current literature and our own data polyphenols have been demonstrated to attenuate type I allergic reactions and contact dermatitis in response to nickel. The use of polyphenols in these diseases will be discussed also in view of MC involvement.o a variety of exogenous and endogenous stimuli. However, MC function is dual since they can initiate pathological events or protect the host against infectious challenges.:The role of MCs in disease will be analyzed in a broad sense, describing cellular and molecular mechanisms related to their involvement in auto-inflammatory diseases, asthma, autoimmune diseases and cancer. On the other hand, their protective role in the course of bacterial, fungal and parasitic infections will also be illustrated.:Mast cells (MCs) bear many receptors that allow them to respond to a variety of exogenous and endogenous stimuli. However, MC function is dual since they can initiate pathological events or protect the host against infectious challenges.
- Subjects :
- 0301 basic medicine
Allergen immunotherapy
Allergy
Endocrinology, Diabetes and Metabolism
Inflammation
Disease
Communicable Diseases
Autoimmune Diseases
03 medical and health sciences
0302 clinical medicine
Neoplasms
Immunology and Allergy
Medicine
Animals
Humans
Mast Cells
Receptor
Immunity, Cellular
business.industry
Mast cell activation
Disease Management
medicine.disease
Immunity disorders
030104 developmental biology
030220 oncology & carcinogenesis
Immunology
medicine.symptom
business
Subjects
Details
- ISSN :
- 22123873
- Volume :
- 20
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- Endocrine, metabolicimmune disorders drug targets
- Accession number :
- edsair.doi.dedup.....d495be33285b867e57b72cb5af749920